Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0463 Transporter Info | ||||
Gene Name | SLC7A10 | ||||
Transporter Name | Asc-type amino acid transporter 1 | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Hepatocellular carcinoma |
13 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC7A10 in hepatocellular carcinoma | [ 1 ] | |||
Location |
5'UTR (cg06501084) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.54E+00 | Statistic Test | p-value:3.11E-14; Z-score:-2.13E+00 | ||
Methylation in Case |
4.46E-01 (Median) | Methylation in Control | 6.85E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC7A10 in hepatocellular carcinoma | [ 1 ] | |||
Location |
TSS1500 (cg18074184) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.31E+00 | Statistic Test | p-value:2.37E-16; Z-score:3.40E+00 | ||
Methylation in Case |
6.58E-01 (Median) | Methylation in Control | 5.03E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC7A10 in hepatocellular carcinoma | [ 1 ] | |||
Location |
TSS1500 (cg25308885) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.44E+00 | Statistic Test | p-value:7.78E-07; Z-score:1.93E+00 | ||
Methylation in Case |
1.93E-01 (Median) | Methylation in Control | 1.34E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC7A10 in hepatocellular carcinoma | [ 1 ] | |||
Location |
TSS1500 (cg02824451) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.45E+00 | Statistic Test | p-value:1.08E-06; Z-score:1.09E+00 | ||
Methylation in Case |
7.37E-02 (Median) | Methylation in Control | 5.08E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC7A10 in hepatocellular carcinoma | [ 1 ] | |||
Location |
TSS1500 (cg00910067) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.05E+00 | Statistic Test | p-value:1.89E-02; Z-score:3.97E-01 | ||
Methylation in Case |
2.56E-01 (Median) | Methylation in Control | 2.43E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC7A10 in hepatocellular carcinoma | [ 1 ] | |||
Location |
TSS1500 (cg18336281) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.07E+00 | Statistic Test | p-value:2.12E-02; Z-score:4.49E-01 | ||
Methylation in Case |
2.39E-01 (Median) | Methylation in Control | 2.23E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC7A10 in hepatocellular carcinoma | [ 1 ] | |||
Location |
TSS200 (cg03523434) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.47E+00 | Statistic Test | p-value:8.13E-18; Z-score:-3.81E+00 | ||
Methylation in Case |
4.82E-01 (Median) | Methylation in Control | 7.09E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC7A10 in hepatocellular carcinoma | [ 1 ] | |||
Location |
TSS200 (cg13272818) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.17E+00 | Statistic Test | p-value:9.37E-05; Z-score:1.05E+00 | ||
Methylation in Case |
4.34E-01 (Median) | Methylation in Control | 3.71E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC7A10 in hepatocellular carcinoma | [ 1 ] | |||
Location |
Body (cg11902539) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.73E+00 | Statistic Test | p-value:1.85E-18; Z-score:-8.32E+00 | ||
Methylation in Case |
5.16E-01 (Median) | Methylation in Control | 8.91E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC7A10 in hepatocellular carcinoma | [ 1 ] | |||
Location |
Body (cg25945642) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.38E+00 | Statistic Test | p-value:8.59E-11; Z-score:-1.84E+00 | ||
Methylation in Case |
4.98E-01 (Median) | Methylation in Control | 6.87E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon11 |
Methylation of SLC7A10 in hepatocellular carcinoma | [ 1 ] | |||
Location |
Body (cg03049846) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.12E+00 | Statistic Test | p-value:2.12E-08; Z-score:-1.38E+00 | ||
Methylation in Case |
6.27E-01 (Median) | Methylation in Control | 7.01E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon12 |
Methylation of SLC7A10 in hepatocellular carcinoma | [ 1 ] | |||
Location |
Body (cg04305036) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.09E+00 | Statistic Test | p-value:1.97E-05; Z-score:-1.02E+00 | ||
Methylation in Case |
5.36E-01 (Median) | Methylation in Control | 5.87E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon13 |
Methylation of SLC7A10 in hepatocellular carcinoma | [ 1 ] | |||
Location |
Body (cg09968457) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:3.77E-05; Z-score:-6.71E-01 | ||
Methylation in Case |
8.09E-01 (Median) | Methylation in Control | 8.29E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Pancretic ductal adenocarcinoma |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC7A10 in pancretic ductal adenocarcinoma | [ 2 ] | |||
Location |
5'UTR (cg26779716) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.30E+00 | Statistic Test | p-value:6.79E-14; Z-score:1.21E+00 | ||
Methylation in Case |
1.10E-01 (Median) | Methylation in Control | 8.44E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC7A10 in pancretic ductal adenocarcinoma | [ 2 ] | |||
Location |
TSS200 (cg22639895) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.29E+00 | Statistic Test | p-value:1.14E-12; Z-score:9.60E-01 | ||
Methylation in Case |
6.91E-02 (Median) | Methylation in Control | 5.35E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC7A10 in pancretic ductal adenocarcinoma | [ 2 ] | |||
Location |
Body (cg00445475) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.40E+00 | Statistic Test | p-value:3.34E-09; Z-score:1.52E+00 | ||
Methylation in Case |
4.13E-01 (Median) | Methylation in Control | 2.95E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC7A10 in pancretic ductal adenocarcinoma | [ 2 ] | |||
Location |
Body (cg06728970) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.08E+00 | Statistic Test | p-value:1.05E-04; Z-score:-8.02E-01 | ||
Methylation in Case |
5.37E-01 (Median) | Methylation in Control | 5.82E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC7A10 in pancretic ductal adenocarcinoma | [ 2 ] | |||
Location |
Body (cg02501410) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.05E+00 | Statistic Test | p-value:5.11E-04; Z-score:-8.39E-01 | ||
Methylation in Case |
7.38E-01 (Median) | Methylation in Control | 7.76E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC7A10 in pancretic ductal adenocarcinoma | [ 2 ] | |||
Location |
Body (cg01454305) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:3.06E-02; Z-score:-1.99E-01 | ||
Methylation in Case |
7.98E-01 (Median) | Methylation in Control | 8.11E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Bladder cancer |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC7A10 in bladder cancer | [ 3 ] | |||
Location |
TSS1500 (cg23331484) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.94E+00 | Statistic Test | p-value:1.90E-08; Z-score:7.97E+00 | ||
Methylation in Case |
5.62E-01 (Median) | Methylation in Control | 2.90E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC7A10 in bladder cancer | [ 3 ] | |||
Location |
TSS1500 (cg02824451) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.29E+00 | Statistic Test | p-value:2.59E-02; Z-score:2.98E+00 | ||
Methylation in Case |
4.65E-02 (Median) | Methylation in Control | 3.61E-02 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC7A10 in bladder cancer | [ 3 ] | |||
Location |
Body (cg03049846) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-2.27E+00 | Statistic Test | p-value:5.30E-09; Z-score:-7.69E+00 | ||
Methylation in Case |
2.66E-01 (Median) | Methylation in Control | 6.03E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC7A10 in bladder cancer | [ 3 ] | |||
Location |
Body (cg09968457) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.16E+00 | Statistic Test | p-value:3.93E-06; Z-score:-5.79E+00 | ||
Methylation in Case |
6.87E-01 (Median) | Methylation in Control | 7.96E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC7A10 in bladder cancer | [ 3 ] | |||
Location |
Body (cg04305036) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.35E+00 | Statistic Test | p-value:5.55E-05; Z-score:-1.49E+01 | ||
Methylation in Case |
3.77E-01 (Median) | Methylation in Control | 5.07E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC7A10 in bladder cancer | [ 3 ] | |||
Location |
Body (cg18031850) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.52E+00 | Statistic Test | p-value:4.53E-03; Z-score:2.67E+00 | ||
Methylation in Case |
2.22E-01 (Median) | Methylation in Control | 1.46E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
9 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC7A10 in breast cancer | [ 4 ] | |||
Location |
TSS1500 (cg23331484) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.84E+00 | Statistic Test | p-value:5.01E-13; Z-score:2.42E+00 | ||
Methylation in Case |
3.87E-01 (Median) | Methylation in Control | 2.10E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC7A10 in breast cancer | [ 4 ] | |||
Location |
TSS1500 (cg18336281) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.19E+00 | Statistic Test | p-value:1.82E-06; Z-score:1.28E+00 | ||
Methylation in Case |
1.72E-01 (Median) | Methylation in Control | 1.44E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC7A10 in breast cancer | [ 4 ] | |||
Location |
TSS1500 (cg25308885) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.13E+00 | Statistic Test | p-value:1.45E-03; Z-score:5.47E-01 | ||
Methylation in Case |
1.43E-01 (Median) | Methylation in Control | 1.26E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC7A10 in breast cancer | [ 4 ] | |||
Location |
TSS1500 (cg00910067) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.09E+00 | Statistic Test | p-value:3.47E-03; Z-score:6.73E-01 | ||
Methylation in Case |
1.85E-01 (Median) | Methylation in Control | 1.70E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC7A10 in breast cancer | [ 4 ] | |||
Location |
TSS200 (cg13272818) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.25E+00 | Statistic Test | p-value:5.24E-08; Z-score:2.89E+00 | ||
Methylation in Case |
3.11E-01 (Median) | Methylation in Control | 2.49E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC7A10 in breast cancer | [ 4 ] | |||
Location |
Body (cg18031850) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:2.05E+00 | Statistic Test | p-value:1.09E-17; Z-score:3.60E+00 | ||
Methylation in Case |
3.55E-01 (Median) | Methylation in Control | 1.73E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC7A10 in breast cancer | [ 4 ] | |||
Location |
Body (cg05976074) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.23E+00 | Statistic Test | p-value:1.71E-11; Z-score:2.15E+00 | ||
Methylation in Case |
3.80E-01 (Median) | Methylation in Control | 3.09E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC7A10 in breast cancer | [ 4 ] | |||
Location |
Body (cg25543755) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.17E+00 | Statistic Test | p-value:8.87E-07; Z-score:9.48E-01 | ||
Methylation in Case |
5.96E-01 (Median) | Methylation in Control | 5.09E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC7A10 in breast cancer | [ 4 ] | |||
Location |
Body (cg04305036) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.10E+00 | Statistic Test | p-value:1.20E-05; Z-score:-1.44E+00 | ||
Methylation in Case |
4.86E-01 (Median) | Methylation in Control | 5.33E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Renal cell carcinoma |
8 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC7A10 in clear cell renal cell carcinoma | [ 5 ] | |||
Location |
TSS1500 (cg23331484) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:2.51E+00 | Statistic Test | p-value:1.23E-11; Z-score:3.20E+00 | ||
Methylation in Case |
3.66E-01 (Median) | Methylation in Control | 1.46E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC7A10 in clear cell renal cell carcinoma | [ 5 ] | |||
Location |
TSS1500 (cg00910067) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.90E+00 | Statistic Test | p-value:4.98E-08; Z-score:4.09E+00 | ||
Methylation in Case |
3.86E-01 (Median) | Methylation in Control | 2.03E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC7A10 in clear cell renal cell carcinoma | [ 5 ] | |||
Location |
TSS1500 (cg25308885) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.27E+00 | Statistic Test | p-value:3.02E-05; Z-score:1.31E+00 | ||
Methylation in Case |
1.48E-01 (Median) | Methylation in Control | 1.17E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC7A10 in clear cell renal cell carcinoma | [ 5 ] | |||
Location |
TSS1500 (cg18336281) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.30E+00 | Statistic Test | p-value:1.10E-04; Z-score:1.68E+00 | ||
Methylation in Case |
1.99E-01 (Median) | Methylation in Control | 1.53E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC7A10 in clear cell renal cell carcinoma | [ 5 ] | |||
Location |
TSS1500 (cg02824451) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.09E+00 | Statistic Test | p-value:1.93E-02; Z-score:4.37E-01 | ||
Methylation in Case |
2.70E-02 (Median) | Methylation in Control | 2.47E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC7A10 in clear cell renal cell carcinoma | [ 5 ] | |||
Location |
Body (cg18031850) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.87E+00 | Statistic Test | p-value:3.50E-06; Z-score:2.45E+00 | ||
Methylation in Case |
1.70E-01 (Median) | Methylation in Control | 9.11E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC7A10 in clear cell renal cell carcinoma | [ 5 ] | |||
Location |
Body (cg05976074) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.42E+00 | Statistic Test | p-value:1.13E-05; Z-score:2.41E+00 | ||
Methylation in Case |
3.60E-01 (Median) | Methylation in Control | 2.53E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC7A10 in clear cell renal cell carcinoma | [ 5 ] | |||
Location |
Body (cg25543755) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.15E+00 | Statistic Test | p-value:3.58E-03; Z-score:1.21E+00 | ||
Methylation in Case |
4.60E-01 (Median) | Methylation in Control | 4.02E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Colon cancer |
8 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC7A10 in colon adenocarcinoma | [ 6 ] | |||
Location |
TSS1500 (cg20982412) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:2.08E+00 | Statistic Test | p-value:3.11E-07; Z-score:8.09E+00 | ||
Methylation in Case |
5.27E-01 (Median) | Methylation in Control | 2.54E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC7A10 in colon adenocarcinoma | [ 6 ] | |||
Location |
TSS1500 (cg05863502) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.13E+00 | Statistic Test | p-value:1.54E-05; Z-score:9.62E-01 | ||
Methylation in Case |
7.02E-01 (Median) | Methylation in Control | 6.20E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC7A10 in colon adenocarcinoma | [ 6 ] | |||
Location |
TSS1500 (cg07646731) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.50E+00 | Statistic Test | p-value:5.90E-04; Z-score:2.56E+00 | ||
Methylation in Case |
2.28E-01 (Median) | Methylation in Control | 1.52E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC7A10 in colon adenocarcinoma | [ 6 ] | |||
Location |
TSS200 (cg14613271) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:2.16E+00 | Statistic Test | p-value:7.81E-06; Z-score:3.32E+00 | ||
Methylation in Case |
6.09E-01 (Median) | Methylation in Control | 2.82E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC7A10 in colon adenocarcinoma | [ 6 ] | |||
Location |
TSS200 (cg04633600) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.68E+00 | Statistic Test | p-value:2.85E-03; Z-score:2.96E+00 | ||
Methylation in Case |
9.21E-02 (Median) | Methylation in Control | 5.48E-02 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC7A10 in colon adenocarcinoma | [ 6 ] | |||
Location |
1stExon (cg02318629) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:4.00E+00 | Statistic Test | p-value:1.26E-08; Z-score:1.32E+01 | ||
Methylation in Case |
5.40E-01 (Median) | Methylation in Control | 1.35E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC7A10 in colon adenocarcinoma | [ 6 ] | |||
Location |
1stExon (cg08022436) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.60E+00 | Statistic Test | p-value:3.21E-06; Z-score:3.53E+00 | ||
Methylation in Case |
4.46E-01 (Median) | Methylation in Control | 2.78E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC7A10 in colon adenocarcinoma | [ 6 ] | |||
Location |
Body (cg00662647) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:4.74E+00 | Statistic Test | p-value:3.27E-05; Z-score:1.28E+01 | ||
Methylation in Case |
4.16E-01 (Median) | Methylation in Control | 8.77E-02 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
10 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC7A10 in colorectal cancer | [ 7 ] | |||
Location |
TSS1500 (cg23331484) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.48E+00 | Statistic Test | p-value:2.38E-05; Z-score:1.32E+00 | ||
Methylation in Case |
3.39E-01 (Median) | Methylation in Control | 2.30E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC7A10 in colorectal cancer | [ 7 ] | |||
Location |
TSS1500 (cg02824451) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:1.21E-03; Z-score:-4.42E-02 | ||
Methylation in Case |
3.48E-02 (Median) | Methylation in Control | 3.54E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC7A10 in colorectal cancer | [ 7 ] | |||
Location |
TSS1500 (cg25308885) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.03E+00 | Statistic Test | p-value:4.88E-03; Z-score:9.08E-02 | ||
Methylation in Case |
9.52E-02 (Median) | Methylation in Control | 9.25E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC7A10 in colorectal cancer | [ 7 ] | |||
Location |
TSS1500 (cg18336281) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.06E+00 | Statistic Test | p-value:1.98E-02; Z-score:3.86E-01 | ||
Methylation in Case |
2.18E-01 (Median) | Methylation in Control | 2.05E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC7A10 in colorectal cancer | [ 7 ] | |||
Location |
TSS200 (cg13272818) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.11E+00 | Statistic Test | p-value:4.17E-04; Z-score:8.78E-01 | ||
Methylation in Case |
4.20E-01 (Median) | Methylation in Control | 3.79E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC7A10 in colorectal cancer | [ 7 ] | |||
Location |
Body (cg03049846) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.26E+00 | Statistic Test | p-value:5.45E-14; Z-score:-5.10E+00 | ||
Methylation in Case |
6.33E-01 (Median) | Methylation in Control | 7.95E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC7A10 in colorectal cancer | [ 7 ] | |||
Location |
Body (cg04305036) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.14E+00 | Statistic Test | p-value:1.24E-10; Z-score:-2.22E+00 | ||
Methylation in Case |
6.18E-01 (Median) | Methylation in Control | 7.06E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC7A10 in colorectal cancer | [ 7 ] | |||
Location |
Body (cg18031850) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:2.06E+00 | Statistic Test | p-value:5.42E-09; Z-score:2.88E+00 | ||
Methylation in Case |
2.35E-01 (Median) | Methylation in Control | 1.14E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC7A10 in colorectal cancer | [ 7 ] | |||
Location |
Body (cg09968457) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:1.30E-03; Z-score:-1.22E+00 | ||
Methylation in Case |
8.90E-01 (Median) | Methylation in Control | 9.10E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC7A10 in colorectal cancer | [ 7 ] | |||
Location |
Body (cg05976074) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.05E+00 | Statistic Test | p-value:3.50E-02; Z-score:5.33E-01 | ||
Methylation in Case |
5.64E-01 (Median) | Methylation in Control | 5.38E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
HIV infection |
10 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC7A10 in HIV infection | [ 8 ] | |||
Location |
TSS1500 (cg23331484) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.45E+00 | Statistic Test | p-value:1.14E-09; Z-score:2.49E+00 | ||
Methylation in Case |
4.54E-01 (Median) | Methylation in Control | 3.14E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC7A10 in HIV infection | [ 8 ] | |||
Location |
TSS1500 (cg25308885) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.36E+00 | Statistic Test | p-value:3.45E-05; Z-score:1.87E+00 | ||
Methylation in Case |
1.58E-01 (Median) | Methylation in Control | 1.16E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC7A10 in HIV infection | [ 8 ] | |||
Location |
TSS1500 (cg00910067) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.19E+00 | Statistic Test | p-value:2.91E-04; Z-score:1.02E+00 | ||
Methylation in Case |
2.14E-01 (Median) | Methylation in Control | 1.80E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC7A10 in HIV infection | [ 8 ] | |||
Location |
TSS1500 (cg02824451) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.22E+00 | Statistic Test | p-value:6.78E-04; Z-score:8.31E-01 | ||
Methylation in Case |
6.24E-02 (Median) | Methylation in Control | 5.12E-02 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC7A10 in HIV infection | [ 8 ] | |||
Location |
TSS1500 (cg18336281) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.15E+00 | Statistic Test | p-value:4.17E-03; Z-score:9.98E-01 | ||
Methylation in Case |
1.96E-01 (Median) | Methylation in Control | 1.70E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC7A10 in HIV infection | [ 8 ] | |||
Location |
TSS200 (cg13272818) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.17E+00 | Statistic Test | p-value:9.10E-04; Z-score:1.32E+00 | ||
Methylation in Case |
3.19E-01 (Median) | Methylation in Control | 2.74E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC7A10 in HIV infection | [ 8 ] | |||
Location |
Body (cg18031850) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.38E+00 | Statistic Test | p-value:1.98E-05; Z-score:1.91E+00 | ||
Methylation in Case |
2.77E-01 (Median) | Methylation in Control | 2.00E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC7A10 in HIV infection | [ 8 ] | |||
Location |
Body (cg04305036) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.08E+00 | Statistic Test | p-value:3.92E-04; Z-score:-1.39E+00 | ||
Methylation in Case |
6.82E-01 (Median) | Methylation in Control | 7.34E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC7A10 in HIV infection | [ 8 ] | |||
Location |
Body (cg03049846) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.04E+00 | Statistic Test | p-value:6.91E-04; Z-score:-1.12E+00 | ||
Methylation in Case |
8.28E-01 (Median) | Methylation in Control | 8.62E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC7A10 in HIV infection | [ 8 ] | |||
Location |
Body (cg05976074) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.06E+00 | Statistic Test | p-value:1.38E-02; Z-score:6.26E-01 | ||
Methylation in Case |
4.69E-01 (Median) | Methylation in Control | 4.41E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Lung adenocarcinoma |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC7A10 in lung adenocarcinoma | [ 9 ] | |||
Location |
TSS1500 (cg23331484) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.39E+00 | Statistic Test | p-value:1.35E-04; Z-score:3.42E+00 | ||
Methylation in Case |
4.36E-01 (Median) | Methylation in Control | 3.14E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC7A10 in lung adenocarcinoma | [ 9 ] | |||
Location |
TSS1500 (cg02824451) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.60E+00 | Statistic Test | p-value:4.66E-03; Z-score:2.83E+00 | ||
Methylation in Case |
1.11E-01 (Median) | Methylation in Control | 6.96E-02 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC7A10 in lung adenocarcinoma | [ 9 ] | |||
Location |
TSS1500 (cg00910067) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.29E+00 | Statistic Test | p-value:1.37E-02; Z-score:1.96E+00 | ||
Methylation in Case |
3.19E-01 (Median) | Methylation in Control | 2.47E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC7A10 in lung adenocarcinoma | [ 9 ] | |||
Location |
TSS200 (cg13272818) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.18E+00 | Statistic Test | p-value:3.70E-02; Z-score:1.65E+00 | ||
Methylation in Case |
3.90E-01 (Median) | Methylation in Control | 3.30E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC7A10 in lung adenocarcinoma | [ 9 ] | |||
Location |
Body (cg18031850) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.79E+00 | Statistic Test | p-value:3.72E-03; Z-score:2.78E+00 | ||
Methylation in Case |
3.36E-01 (Median) | Methylation in Control | 1.88E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC7A10 in lung adenocarcinoma | [ 9 ] | |||
Location |
Body (cg25543755) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.17E+00 | Statistic Test | p-value:7.07E-03; Z-score:1.58E+00 | ||
Methylation in Case |
6.79E-01 (Median) | Methylation in Control | 5.82E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Panic disorder |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC7A10 in panic disorder | [ 10 ] | |||
Location |
TSS1500 (cg23331484) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-8.48E-01 | Statistic Test | p-value:1.09E-03; Z-score:-4.71E-01 | ||
Methylation in Case |
-1.87E+00 (Median) | Methylation in Control | -1.58E+00 (Median) | ||
Studied Phenotype |
Panic disorder[ ICD-11:6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC7A10 in panic disorder | [ 10 ] | |||
Location |
Body (cg09968457) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.13E+00 | Statistic Test | p-value:1.21E-02; Z-score:-5.76E-01 | ||
Methylation in Case |
1.91E+00 (Median) | Methylation in Control | 2.16E+00 (Median) | ||
Studied Phenotype |
Panic disorder[ ICD-11:6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC7A10 in panic disorder | [ 10 ] | |||
Location |
Body (cg04305036) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.06E+00 | Statistic Test | p-value:3.38E-02; Z-score:2.27E-01 | ||
Methylation in Case |
1.14E+00 (Median) | Methylation in Control | 1.07E+00 (Median) | ||
Studied Phenotype |
Panic disorder[ ICD-11:6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC7A10 in papillary thyroid cancer | [ 11 ] | |||
Location |
TSS1500 (cg23331484) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.27E+00 | Statistic Test | p-value:1.19E-02; Z-score:5.06E-01 | ||
Methylation in Case |
1.75E-01 (Median) | Methylation in Control | 1.38E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC7A10 in papillary thyroid cancer | [ 11 ] | |||
Location |
Body (cg05976074) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.09E+00 | Statistic Test | p-value:9.26E-03; Z-score:4.96E-01 | ||
Methylation in Case |
2.68E-01 (Median) | Methylation in Control | 2.45E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC7A10 in papillary thyroid cancer | [ 11 ] | |||
Location |
Body (cg18031850) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.18E+00 | Statistic Test | p-value:1.03E-02; Z-score:5.91E-01 | ||
Methylation in Case |
1.58E-01 (Median) | Methylation in Control | 1.34E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Atypical teratoid rhabdoid tumor |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC7A10 in atypical teratoid rhabdoid tumor | [ 12 ] | |||
Location |
Body (cg03049846) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.51E+00 | Statistic Test | p-value:2.51E-04; Z-score:-7.08E-01 | ||
Methylation in Case |
8.64E-02 (Median) | Methylation in Control | 1.31E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC7A10 in atypical teratoid rhabdoid tumor | [ 12 ] | |||
Location |
Body (cg04305036) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.05E+00 | Statistic Test | p-value:6.60E-04; Z-score:7.81E-01 | ||
Methylation in Case |
8.89E-01 (Median) | Methylation in Control | 8.44E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC7A10 in atypical teratoid rhabdoid tumor | [ 12 ] | |||
Location |
Body (cg05976074) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.14E+00 | Statistic Test | p-value:2.00E-03; Z-score:6.02E-01 | ||
Methylation in Case |
1.21E-01 (Median) | Methylation in Control | 1.06E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC7A10 in atypical teratoid rhabdoid tumor | [ 12 ] | |||
Location |
Body (cg09968457) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.08E+00 | Statistic Test | p-value:1.28E-02; Z-score:-6.66E-01 | ||
Methylation in Case |
7.26E-01 (Median) | Methylation in Control | 7.86E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Prostate cancer |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC7A10 in prostate cancer | [ 13 ] | |||
Location |
Body (cg14331316) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.47E+00 | Statistic Test | p-value:5.79E-03; Z-score:3.16E+00 | ||
Methylation in Case |
7.98E-01 (Median) | Methylation in Control | 5.43E-01 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC7A10 in prostate cancer | [ 13 ] | |||
Location |
Body (cg24141378) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.04E+00 | Statistic Test | p-value:1.28E-02; Z-score:2.20E+00 | ||
Methylation in Case |
9.22E-01 (Median) | Methylation in Control | 8.85E-01 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC7A10 in prostate cancer | [ 13 ] | |||
Location |
Body (cg10734665) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.37E+00 | Statistic Test | p-value:1.86E-02; Z-score:-3.00E+00 | ||
Methylation in Case |
4.20E-01 (Median) | Methylation in Control | 5.75E-01 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC7A10 in prostate cancer | [ 13 ] | |||
Location |
Body (cg02641517) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.10E+00 | Statistic Test | p-value:4.97E-02; Z-score:5.02E+00 | ||
Methylation in Case |
8.52E-01 (Median) | Methylation in Control | 7.75E-01 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.